ARCHIVES

NCI Advisors Approve New Grant Programs Worth $100 Million

This article is from The Cancer Letter archive.

Vol. 35 No. 12 | March 27, 2009

Download PDF Visit The Full Archive

Related Articles

Wistar Investigators Report Oncogene Relation to Burkitt’s

November 26, 1982

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

NCI Dispute GAO Charge That Cancer Control Contracts Were Mishandled

August 15, 1980

In Brief: NCI Holds Paylines To 160, 165 for Now While Anticipating Another OMB Rescission Request

November 14, 1986

In Brief: WHI Revises Protocol After Study Finds High Rate Of Endometrial Hyperplasia

January 27, 1995

Phase III Tecemotide Trial Fails OS Endpoint; Second Trial Planned After Subgroup Analysis

December 27, 2013